ESTALIS CONTINUOUS transdermal patch 50 µg/24 h+250 µg/24 h
Nombre local: ESTALIS CONTINUOUS Transdermal patch 50 µg/24 h+250 µg/24 hPaís: Australia
Laboratorio: Novartis Pharmaceuticals Australia Pty Ltd
Vía: Vía transdérmica
Forma: Parche transdérmico
ATC: Norethisterone and estrogen (G03FA01)